GRAIL, Inc. (GRAL) Fair Value 2026

GRAL · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (17/100)

Quick Summary — As of 2026-08-27, GRAIL, Inc. (GRAL) trades at $82.50. QOC: 6.2/10. Value Trap Risk: 17/100 (SAFE). 0/13 models active.

Key Facts

Ticker
GRAL
Price
$82.50
Quality Score
6.2/10
Value Trap Risk
17/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give GRAL?

0 Intrinsic Value Models vs. Current Price ($82.50)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is GRAIL, Inc. (GRAL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, GRAIL, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About GRAL?

0 of 13 models are currently active for GRAL. See which stocks rank higher →

How Does GRAL Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, GRAL ranks #36 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

The Diagnostics & Research sector introduces analytical considerations specific to pharmaceutical industry businesses. For GRAIL, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is GRAL a Value Trap?

CirclFi's Value Trap algorithm assigns GRAL a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for GRAIL, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, GRAIL, Inc. scores 6.2 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GRAL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy GRAIL, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

11 related Diagnostics & Research stocks with 13-model coverage

BDSXBiodesix, Inc.QOC 6.3IMDXInsight Molecular Diagnostics Inc.QOC 6.1AWHLAspira Women's Health Inc.QOC 6.4QUCYQuantum Cyber N.V.QOC 5.6PSNLPersonalis, Inc.QOC 6.4OPKOPKO Health, Inc.QOC 5.6QGENQiagen N.V.QOC 3.2SHCSotera Health CompanyQOC 8.1GHGuardant Health, Inc.QOC 7.0IDXXIDEXX Laboratories, Inc.QOC 9.5MEDPMedpace Holdings, Inc.QOC 9.3

Read investment analysis: BDSX · IMDX · AWHL · QUCY · PSNL · OPK · QGEN · SHC · GH · IDXX · MEDP

Which Other Stocks Have a Similar Quality Score to GRAL?

7 companies across all industries closest to GRAL’s Quality of Company score of 6.2/10.

EVOEvotec SEQOC 6.2DTILPrecision BioSciences, Inc.QOC 6.2GLDGGoldMining Inc.QOC 6.2PHUNPhunware, Inc.QOC 6.2CLDXCelldex Therapeutics, Inc.QOC 6.2CTRICenturi Holdings, Inc.QOC 6.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: EVO · DTIL · GLDG · PHUN · CLDX · CTRI · NVDA

What Else Do Investors Ask About GRAIL, Inc.’s Valuation?

What is GRAIL, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for GRAIL, Inc. (GRAL). The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GRAL overvalued or undervalued right now?

At $82.50, 0 of 0 active models suggest GRAL may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits GRAIL, Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 6.2 mean for GRAL?

GRAIL, Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on GRAL?

CirclFi analyzes GRAL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is GRAL a value trap in 2026?

GRAIL, Inc.'s Value Trap score is 17/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns GRAIL, Inc. (GRAL) a Quality of Company score of 6.2/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/GRAL/ · Methodology
Primary sources for this GRAL valuation
  • Financial statements: GRAIL, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001699031) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for GRAL as of ; valuations recomputed .